Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Oslo - Delayed Quote NOK

BerGenBio ASA (BGBIO.OL)

1.7920
-0.0260
(-1.43%)
As of 9:58:31 AM GMT+2. Market Open.
Currency in NOK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
848
848
354
389
774
Operating Expense
152,081
152,081
192,173
306,024
315,236
Operating Income
-151,233
-151,233
-191,819
-305,635
-314,462
Net Non Operating Interest Income Expense
11,953
11,953
1,418
3,513
5,100
Pretax Income
-139,282
-139,282
-190,401
-302,122
-309,364
Net Income Common Stockholders
-139,282
-139,282
-190,401
-302,122
-309,364
Diluted NI Available to Com Stockholders
-139,282
-139,282
-190,401
-302,122
-309,364
Basic EPS
-3.95
-3.95
-13.30
-341.00
-303.91
Diluted EPS
-3.95
-3.95
-13.30
-341.00
-303.91
Basic Average Shares
35,276.6350
35,276.6350
14,313.0150
886.3640
1,018.7560
Diluted Average Shares
35,276.6350
35,276.6350
14,313.0150
886.3640
1,018.7560
Total Operating Income as Reported
-151,234
-151,234
-191,819
-305,635
-314,464
Rent Expense Supplemental
994
994
3,727
3,331
2,447
Total Expenses
152,081
152,081
192,173
306,024
315,236
Net Income from Continuing & Discontinued Operation
-139,282
-139,282
-190,401
-302,122
-309,364
Normalized Income
-139,282
-139,282
-190,401
-302,122
-309,364
Interest Income
16,653
16,653
3,055
2,949
3,130
Interest Expense
4,700
4,700
578
321
53
Net Interest Income
11,953
11,953
1,418
3,513
5,100
EBIT
-134,582
-134,582
-189,823
-301,801
-309,311
EBITDA
-134,126
-134,126
-189,600
-300,918
-307,999
Reconciled Depreciation
456
456
223
883
1,312
Net Income from Continuing Operation Net Minority Interest
-139,282
-139,282
-190,401
-302,122
-309,364
Normalized EBITDA
-134,126
-134,126
-189,600
-300,918
-307,999
12/31/2021 - 4/7/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SOFTX.OL SoftOx Solutions AS
0.0646
+1.25%
 
MVIR.ST Medivir AB (publ)
1.5500
-3.13%
 
LYTIX.OL Lytix Biopharma AS
5.22
-2.97%
 
ONCO.ST Oncopeptides AB (publ)
1.9400
-0.31%
 
HNSA.ST Hansa Biopharma AB (publ)
25.10
+12.56%
 
VYNE VYNE Therapeutics Inc.
1.8400
-1.08%
 
GUBRA.CO Gubra A/S
349.00
-3.38%
 
IBO Impact BioMedical Inc.
0.4258
+0.34%
 
ARCT Arcturus Therapeutics Holdings Inc.
12.65
+3.94%
 
CAPR Capricor Therapeutics, Inc.
13.15
-5.33%